Tiagabine in the management of postencephalitic epilepsy and impulse control disorder

Epilepsy and Behavior

Volumn 3, Issue 2, 2002, Pages 190-194

  Kaufman, Kenneth R ^a   Kugler, Steven L ^a   Sachdeo, Rajesh C ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Aggression; Anticonvulsants; Encephalitis; Epilepsy; Impulse control disorders; Therapeutic window; Tiagabine; Treatment

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; ACICLOVIR; AMOXICILLIN; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CARBAMAZEPINE; COTRIMOXAZOLE; FELBAMATE; GABAPENTIN; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; SERTRALINE; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

AGGRESSION; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR; BEHAVIOR DISORDER; BEHAVIOR THERAPY; CASE REPORT; CHILD; CLINICAL FEATURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; ENCEPHALITIS; EPILEPTIC STATE; GABAERGIC SYSTEM; GRAND MAL EPILEPSY; HUMAN; IRRITABILITY; MALE; MENTAL DISEASE; NEUROLOGIC DISEASE; OTITIS MEDIA; PATIENT COUNSELING; PERSONALITY DISORDER; PHARYNGITIS; SUICIDE ATTEMPT; SYMPTOM; TREATMENT OUTCOME;

EID: 0036554688     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1006/ebeh.2002.0319     Document Type: Article

References (31)

1. Post RM, Ketter TA, Denicoff K, et al. The place of anticonvulsant therapy in bipolar illness. Psychopharmacology 1996;128: 115-29.
2. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs. lithium and placebo in the treatment of mania. JAMA 1994;271:918-24.
3. Calabrese JR, Bowden CL, McElroy SL, et al. Spectrum of lamotrigine in treatment-refractory bipolar disorder. Am J Psychiatry 1999;156:1019-23.
4. Kaufman KR. Adjunctive tiagabine treatment of psychiatric disorders: three cases. Ann Clin Psychiatry 1998;10:181-4.
5. Marcotte D. Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affective Disord 1998;50:245-51.
6. Shelton RC. Mood-stabilizing drugs in depression. J Clin Psychiatry 1999;60(suppl 5):37-40.
7. Maltese TM. Adjunctive lamotrigine treatment for major depression (letter). Am J Psychiatry 1999;156:1833.
8. Keck PE Jr, Taylor VE, Tugrul KC, McElroy SL, Bennet JA. Valproate treatment of panic disorder and lactate-induced panic attacks. Biol Psychiatry 1993;33:542-6.
9. Pande AC, Davidson JR, Jefferson JW, et al. Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol 1999;19:341-8.
10. Brady KT, Myrick H, McElroy S. The relationship between substance use disorders, impulse control disorders, and pathological aggression. Am J Addict 1998;7:221-30.
11. McElroy SL. Recognition and treatment of DSM-IV intermittent explosive disorder. J Clin Psychiatry 1999;60(suppl 15): 12-6.
12. Neppe VM. Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEG temporal lobe abnormalities. J Clin Psychiatry 1983;44:326-31.
13. Fein S. Treatment of drug-refractory schizophrenia. Psychiatr Ann 1998;28:215-9.
14. Nuffield EJA. Electro-clinical correlations in childhood epilepsy. Epilepsia 1961;2:178-96.
15. Nuffield EJA. Neurophysiology and behavior problems in epileptic children. J Ment Sci 1961;107:438-58.
16. Kaufman KR, Harris R, Shaffer D. Problems in the categorization of child and adolescent EEGs. J Child Psychol Psychiatry 1980;21:333-41.
17. Monroe RR. Anticonvulsants in the treatment of aggression. J Nerv Ment Dis 1975;160:119-26.
18. Wilcox J. Divalproex sodium in the treatment of aggressive behavior. Ann Clin Psychiatry 1994;6:17-20.
19. Fava M: Psychopharmacologic treatment of pathologic aggression. Psychiatr Clin North Am 1997;20:427-51.
20. Wroblewski BA, Joseph AB, Kupfer J, Kalliel K. Effectiveness of valproic acid on destructive and aggressive behaviours in patients with acquired brain injury. Brain Injury 1997;11:37-47.
21. Tariot PN, Erb R, Podgorski CA, et al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 1998;155:54-61.
22. Yehuda R. Managing anger and aggression in patients with posttraumatic stress disorder. J Clin Psychiatry 1999;60(suppl 15):33-7.
23. Mattes JA. Comparative effectiveness of carbamazepine and propranolol for rage outbursts. J Neuropsychiatry Clin Neurosci 1990;2:159-64.
24. Kafantaris V, Campbell M, Padron-Gayol MV, Small AM, Locascio JJ, Rosenberg CR. Carbamazepine in hospitalized aggressive conduct disorder children: an open pilot study. Psychopharmacol Bull 1992;28:193-9.
25. McElroy S, Soutullo CA, Beckman DA, Taylor P, Keck PE Jr. DSM-IV intermittent explosive disorder: a report of 27 cases. J Clin Psychiatry 1998;59:203-10.
26. Barratt ES, Stanford MS, Felthous AR, Kent TA. The effects of phenytoin on impulsive and premeditated aggression: a controlled study. J Clin Psychopharmacol 1997;17:341-9.
27. Potegal M. Differential effects of ethyl (R,S)-nipecotate on the behaviors of highly and minimally aggressive female golden hamsters. Psychopharmacology 1986;89:444-8.
28. Molina V, Ciesielski L, Gobaille S, Mandel P. Effects of the potentiation of the GABAergic neurotransmission in the olfactory bulbs on mouse-killing behavior. Pharmacol Biochem Behav 1986;24:657-64.
29. Diagnostic and statistical manual of mental disorders, fourth edition. Washington, DC: American Psychiatric Association, 1994.
30. Hohman LB. Post encephalitic behavior disorders in children. Johns Hopkins Bull 1922;33:372-5.
31. Strauss AA, Kephart NC. Psychopathology and education of the brain-injured child. New York: Grune & Stratton, 1955.